MedPath

NOVA SOUTHEASTERN UNIVERSITY

🇺🇸United States
Ownership
-
Established
1964-01-01
Employees
4.5K
Market Cap
-
Website
http://www.nova.edu

Global Clinical Trial Launches to Test Sipavibart as Potential Long COVID Treatment

Nova Southeastern University researchers have begun a clinical trial testing AstraZeneca's monoclonal antibody sipavibart as a potential treatment for Long COVID, funded by the Schmidt Initiative for Long COVID.

© Copyright 2025. All Rights Reserved by MedPath